ORM-5029 Antibody
ORM-5029 is a human epidermal growth factor receptor 2 (HER2) -targeting antibody-drug conjugate (ADC) for cancer research, formed by conjugating the potent GSPT1 degrader SMol006 with Pertuzumab.
Product Specifications
Target
Antibody-Drug Conjugates (ADCs)
Conjugation
Unconjugated
Concentration
12.26 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
152.59 kDa (Predicted)
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
E-CL-H0664-01 24 Tests
Human PDGFRβ -Platelet Derived Growth Factor Receptor Beta- CLIA Kit
Sign In for Pricing
View Details E-CL-H0664-02 48 Tests
Human PDGFRβ -Platelet Derived Growth Factor Receptor Beta- CLIA Kit
Sign In for Pricing
View Details E-CL-H0664-03 96 Tests
Human PDGFRβ -Platelet Derived Growth Factor Receptor Beta- CLIA Kit
Sign In for Pricing
View Details E-CL-H0664-04 5x 96 Tests
Human PDGFRβ -Platelet Derived Growth Factor Receptor Beta- CLIA Kit
Sign In for Pricing
View Details E-CL-H0664-05 10x 96 Tests
Human PDGFRβ -Platelet Derived Growth Factor Receptor Beta- CLIA Kit
Sign In for Pricing
View Details